Research and Progress of Implantable Cardiovascular Materials and Devices

References

[[1]] Roth G, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al.; the GBD 2017 Causes of Death Collaborators. Global, regional, and national age–sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736–88.

[[2]] The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2019: an updated summary. Chin Circ J 2020;35(9):833–54. Chinese.

[[3]] Jinnouchi H, Torii S, Sakamoto A, Kolodgie FD, Virmani R, Finn AV. Fully bioresorbable vascular scaffolds: lessons learned and future directions. Nat Rev Cardiol 2019;16(5):286–304.

[[4]] Yang L, Luo R, Lei Y, Wang Y. Frontier research and development of minimally invasive and interventional fully biodegradable and heart valve. Mater Rep 2019;33(1):40–7.

[[5]] Zhang B, Yao R, Hu C, Maitz MF, Wu H, Liu K, et al. Epigallocatechin gallate mediated sandwich-like coating for mimicking endothelium with sustained therapeutic nitric oxide generation and heparin release. Biomaterials 2021;269:120418.

[[6]] Yang L, Wu H, Lu L, He Q, Xi B, Yu H, et al. A tailored extracellular matrix (ECM)- mimetic coating for cardiovascular stents by stepwise assembly of hyaluronic acid and recombinant human type III collagen. Biomaterials 2021;276:121055.

[[7]] Yang F, Xu L, Kuang D, Ge Y, Guo G, Wang Y. Polyzwitterion-crosslinked hybrid tissue with antithrombogenicity, endothelialization, anticalcification properties. Chem Eng J 2021;410:128244.

[[8]] Yu T, Chen X, Zhuang W, Tian Y, Liang Z, Kong Q, et al. Nonglutaraldehyde treated porcine pericardium with good biocompatibility, reduced calcification and improved anti-coagulation for bioprosthetic heart valve applications. Chem Eng J 2021;414:128900.